The WRITTEN-HEART study (expressive writing for heart healing): Rationale and design of a randomized controlled clinical trial of expressive writing in coronary patients referred to residential cardiac rehabilitation

Health and Quality of Life Outcomes

Volumn 9, Issue , 2011, Pages

  Manzoni, Gian Mauro ^a,b   Castelnuovo, Gianluca ^a,b,c   Molinari, Enrico ^a,b,c  

^a ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^b UNIVERSITY OF BERGAMO   (Italy)

^c UNIVERSITÀ CATTOLICA DEL SACRO CUORE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOVASCULAR RISK; CHRONIC DISEASE; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; COPING BEHAVIOR; CORONARY ARTERY DISEASE; DEPRESSION; FOLLOW UP; HEALING; HEART DISEASE; HEART REHABILITATION; HUMAN; ISCHEMIC HEART DISEASE; MENTAL STRESS; PERSONAL EXPERIENCE; PERSONALITY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; STUDY DESIGN; WRITING; ADAPTIVE BEHAVIOR; ANXIETY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; ITALY; PSYCHOLOGICAL ASPECT; SICKNESS IMPACT PROFILE;

ADAPTATION, PSYCHOLOGICAL; ANXIETY; CORONARY DISEASE; DEPRESSION; FOLLOW-UP STUDIES; HUMANS; ITALY; QUALITY OF LIFE; SICKNESS IMPACT PROFILE; STRESS, PSYCHOLOGICAL; WRITING;

EID: 79959986480     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-9-51     Document Type: Article

References (52)

1. WHO Fact sheet N°317. WHO., http://www.who.int/mediacentre/factsheets/fs317/en/index.html
2. O'Keefe JH, Carter MD, Lavie CJ. Primary and secondary prevention of cardiovascular diseases: a practical evidence-based approach. Mayo Clin Proc 2009, 84(8):741-757. 10.4065/84.8.741, 2719528, 19648392.
3. Lear SA, Ignaszewski A. Cardiac rehabilitation: a comprehensive review. Curr Control Trials Cardiovasc Med 2001, 2(5):221-232. 10.1186/CVM-2-5-221, 59530, 11806801.
4. Ades PA. Cardiac rehabilitation and secondary prevention of coronary heart disease. N Engl J Med 2001, 345(12):892-902. 10.1056/NEJMra001529, 11565523.
5. Rozanski A, Blumenthal JA, Davidson KW, Saab PG, Kubzansky L. The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology. J Am Coll Cardiol 2005, 45(5):637-651. 10.1016/j.jacc.2004.12.005, 15734605.
6. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994, 51(1):8-19.
7. Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 1999, 99(16):2192-2217.
8. Dobbels F. Does every cardiologist need a psychologist?. Eur Heart J 2007, 28(24):2964-2966. 10.1093/eurheartj/ehm522, 18029363.
9. Linden W, Phillips MJ, Leclerc J. Psychological treatment of cardiac patients: a meta-analysis. Eur Heart J 2007, 28(24):2972-2984. 10.1093/eurheartj/ehm504, 17984133.
10. Pennebaker JW, Beall SK. Confronting a traumatic event: toward an understanding of inhibition and disease. J Abnorm Psychol 1986, 95(3):274-281.
11. Smyth JM, Pennebaker JW. Exploring the boundary conditions of expressive writing: In search of the right recipe. Br J Health Psychol 2008, 13(Pt 1):1-7.
12. Gidron Y, Peri T, Connolly JF, Shalev AY. Written Disclosure in Posttraumatic Stress Disorder: Is It Benefical for the Patient. The Journal of Nervous and Mental Disease 1996, 184(8):505-506. 10.1097/00005053-199608000-00009, 8752081.
13. Sloan DM, Marx BP. Taking Pen to Hand: Evaluating Theories Underlying the Written Disclosure Paradigm. Clinical Psychology: Science and Practice 2004, 11(2):121-137.
14. Frisina PG, Borod JC, Lepore SJ. A meta-analysis of the effects of written emotional disclosure on the health outcomes of clinical populations. J Nerv Ment Dis 2004, 192(9):629-634. 10.1097/01.nmd.0000138317.30764.63, 15348980.
15. Stanton AL, Danoff-Burg S, Sworowski LA, Collins CA, Branstetter AD, Rodriguez-Hanley A, Kirk SB, Austenfeld JL. Randomized, controlled trial of written emotional expression and benefit finding in breast cancer patients. J Clin Oncol 2002, 20(20):4160-4168. 10.1200/JCO.2002.08.521, 12377959.
16. Walker BL, Nail LM, Croyle RT. Does emotional expression make a difference in reactions to breast cancer?. Oncol Nurs Forum 1999, 26(6):1025-1032.
17. Low CA, Stanton AL, Danoff-Burg S. Expressive disclosure and benefit finding among breast cancer patients: mechanisms for positive health effects. Health Psychol 2006, 25(2):181-189.
18. Low CA, Stanton AL, Bower JE, Gyllenhammer L. A randomized controlled trial of emotionally expressive writing for women with metastatic breast cancer. Health Psychol 2010, 29(4):460-466. 3128513, 20658835.
19. Kelley JE, Lumley MA, Leisen JC. Health effects of emotional disclosure in rheumatoid arthritis patients. Health Psychol 1997, 16(4):331-340.
20. Gillis ME, Lumley MA, Mosley-Williams A, Leisen JC, Roehrs T. The health effects of at-home written emotional disclosure in fibromyalgia: a randomized trial. Ann Behav Med 2006, 32(2):135-146. 10.1207/s15324796abm3202_11, 2935262, 16972811.
21. Mann T. Effects of future writing and optimism on health behaviors in HIV-infected women. Ann Behav Med 2001, 23(1):26-33. 10.1207/S15324796ABM2301_5, 11302353.
22. Petrie KJ, Fontanilla I, Thomas MG, Booth RJ, Pennebaker JW. Effect of written emotional expression on immune function in patients with human immunodeficiency virus infection: a randomized trial. Psychosom Med 2004, 66(2):272-275. 10.1097/01.psy.0000116782.49850.d3, 15039514.
23. de Moor C, Sterner J, Hall M, Warneke C, Gilani Z, Amato R, Cohen L. A pilot study of the effects of expressive writing on psychological and behavioral adjustment in patients enrolled in a Phase II trial of vaccine therapy for metastatic renal cell carcinoma. Health Psychol 2002, 21(6):615-619.
24. Rosenberg HJ, Rosenberg SD, Ernstoff MS, Wolford GL, Amdur RJ, Elshamy MR, Bauer-Wu SM, Ahles TA, Pennebaker JW. Expressive disclosure and health outcomes in a prostate cancer population. Int J Psychiatry Med 2002, 32(1):37-53. 10.2190/AGPF-VB1G-U82E-AE8C, 12075915.
25. Norman SA, Lumley MA, Dooley JA, Diamond MP. For whom does it work? Moderators of the effects of written emotional disclosure in a randomized trial among women with chronic pelvic pain. Psychosom Med 2004, 66(2):174-183. 10.1097/01.psy.0000116979.77753.74, 15039501.
26. McGuire KM, Greenberg MA, Gevirtz R. Autonomic effects of expressive writing in individuals with elevated blood pressure. J Health Psychol 2005, 10(2):197-209. 10.1177/1359105305049767, 15723890.
27. Solano L, Donati V, Pecci F, Persichetti S, Colaci A. Postoperative course after papilloma resection: effects of written disclosure of the experience in subjects with different alexithymia levels. Psychosom Med 2003, 65(3):477-484. 10.1097/01.PSY.0000035781.74170.F1, 12764222.
28. Solano L, Pepe L, Donati V, Persichetti S, Laudani G, Colaci A. Differential health effects of written processing of the experience of a surgical operation in high- and low-risk conditions. J Clin Psychol 2007, 63(4):357-369. 10.1002/jclp.20355, 17279528.
29. Ullrich PA, Lutgendorf SL. Journaling about stressful events: Effects of cognitive processing and emotional expression. Annals of Behavioral Medicine 2002, 24(244-250).
30. Affleck G, Tennen H, Croog S, Levine S. Causal attribution, perceived benefits, and morbidity after a heart attack: an 8-year study. J Consult Clin Psychol 1987, 55(1):29-35.
31. Davis CG, Nolen-Hoeksema S, Larson J. Making sense of loss and benefiting from the experience: two construals of meaning. J Pers Soc Psychol 1998, 75(2):561-574.
32. Mendola R, Tennen H, Affleck G, McCann L, Fitzgerald T. Appraisal and adaptation among women with impaired fertility. Cognitive Therapy and Research 1990, 14(1):79-93.
33. Lumley MA, Tojek TM, Macklem DJ. The effects of written emotional disclosure among repressive and alexithymic people. The Writing Cure: How Expressive Writing Promotes Health and Emotional Well-Being 2002, 75-95. Washington DC: American Psychological Association, Lepore SJ, Smyth JM.
34. Stanton AL, Danoff-Burg S, Cameron CL, Bishop M, Collins CA, Kirk SB, Sworowski LA, Twillman R. Emotionally expressive coping predicts psychological and physical adjustment to breast cancer. J Consult Clin Psychol 2000, 68(5):875-882.
35. Stanton AL, Kirk SB, Cameron CL, Danoff-Burg S. Coping through emotional approach: scale construction and validation. J Pers Soc Psychol 2000, 78(6):1150-1169.
36. Zakowski SG, Ramati A, Morton C, Johnson P, Flanigan R. Written emotional disclosure buffers the effects of social constraints on distress among cancer patients. Health Psychol 2004, 23(6):555-563.
37. Frattaroli J. Experimental disclosure and its moderators: a meta-analysis. Psychol Bull 2006, 132(6):823-865.
38. Cohen J. Statistical power analysis for the behavioral sciences (2nd ed.). 1998, Hillsdale, N.Y.: Lawrence Earlbaum Associates.
39. Ware JE, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: Construction of scales and preliminary tests of reliability and validity. Medical Care 1996, 34(3):220-233. 10.1097/00005650-199603000-00003, 8628042.
40. Apolone G, Mosconi P, Quattrociocchi L, Gianicolo EAL, Groth N, Ware JE. QUESTIONARIO SULLO STATO DI SALUTE SF-12 Versione italiana. 2005, Milano: Istituto di Ricerche Farmacologiche Mario Negri.
41. Tedeschi RG, Calhoun LG. The Posttraumatic Growth Inventory: Measuring the positive legacy of trauma. Journal of Traumatic Stress 1996, 9(3):455-471. 10.1002/jts.2490090305, 8827649.
42. Cann A, Calhoun LG, Tedeschi RG, Taku K, Vishnevsky T, Triplett KN, Danhauer SC. A short form of the Posttraumatic Growth Inventory. Anxiety Stress Coping 2009, 1-11.
43. Prati G, Pietrantoni L. Crescita post-traumatica: un'opportunità dopo il trauma?. Psicoterapia Cognitiva e Comportamentale 2006, 12(6):133-144.
44. Stanton AL, Danoff-Burg S, Huggins ME. The first year after breast cancer diagnosis: hope and coping strategies as predictors of adjustment. Psychooncology 2002, 11(2):93-102. 10.1002/pon.574, 11921325.
45. Denollet J. DS14: standard assessment of negative affectivity, social inhibition, and Type D personality. Psychosom Med 2005, 67(1):89-97. 10.1097/01.psy.0000149256.81953.49, 15673629.
46. Carver CS. You want to measure coping but your protocol's too long: consider the brief COPE. Int J Behav Med 1997, 4(1):92-100. 10.1207/s15327558ijbm0401_6, 16250744.
47. Conti L. Repertorio delle Scale di Valutazione in Psichiatria. 1999, Firenze: S.E.E. Società Editrice Europea di Nicodemo Maggiulli & C. snc.
48. Kwok OM, Underhill AT, Berry JW, Luo W, Elliott TR, Yoon M. Analyzing Longitudinal Data with Multilevel Models: An Example with Individuals Living with Lower Extremity Intra-articular Fractures. Rehabil Psychol 2008, 53(3):370-386. 2613314, 19649151.
49. Singer JD, Willett JB. Applied longitudinal data analysis: Modeling change and event occurrence. 2003, New York: Oxford University Press.
50. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993, 118(8):622-629.
51. Oldridge NB. Outcome assessment in cardiac rehabilitation. Health-related quality of life and economic evaluation. J Cardiopulm Rehabil 1997, 17(3):179-194. 10.1097/00008483-199705000-00005, 9187984.
52. Smyth JM, Nazarian D, Arigo D. Expressive Writing in the Clinical Context. Emotion Regulation 2008, Springer, Nyklíček I, Vingerhoets A, Zeelenberg M.